BCAB vs CB · $5.9M cap vs P/E 14, rev $59.40B
Bioatla Inc (BCAB) versus Chubb Ltd (CB) — a side-by-side from cached financials, not a winner call.
Bioatla Inc (BCAB) is a biotechnology company listed on NASDAQ.
Chubb Ltd (CB) is a insurance - property & casualty company listed on US.
Latest reported BCAB revenue for 2023-09-30 was $0. Net income was -$33.3M. BCAB currently screens at market cap $5.9M.
Latest reported CB revenue for 2025-12-31 was $59.40B. Net income was $10.31B. Revenue was up 6.5% from 2024-12-31 to 2025-12-31. CB currently screens at market cap $114.26B and trailing P/E 13.7.
BCAB currently screens at market cap $5.9M. CB currently screens at market cap $114.26B and trailing P/E 13.7.
Not investment advice. Open the BCAB and CB stock pages for the full models.
Not investment advice.